Q: What is Adalimumab used for?

Adalimumab is used to treat the following conditions: Rheumatoid arthritis Juvenile idiopathic arthritis Psoriatic arthritis Others

Q: How does Adalimumab work?

Mechanism of Action Adalimumab belongs to a class of medications known as tumor necrosis factor (TNF) blockers. TNF is a protein naturally produced by the immune system that helps regulate the body's inflammatory response. In people with certain autoimmune diseases, the body produces an excess of this protein, which leads to chronic inflammation and tissue damage. This medication works by targeting and binding to TNF-alpha molecules. By attaching to these proteins, adalimumab prevents them from interacting with receptors on the surface of cells. This process helps to: Reduce the overall inflammatory response in the body. Decrease swelling, pain, and stiffness in affected areas, such as the joints, skin, or digestive tract. Slow the progression of structural damage caused by chronic inflammation. Because adalimumab specifically targets a component of the immune system to manage disease activity, it is classified as a biologic medication.

Q: What are the brand names for Adalimumab?

Adalimumab is sold under the brand name Humira .

Q: What are the active ingredients in Adalimumab?

The active ingredient in Adalimumab is adalimumab .

Q: What are the side effects of Adalimumab?

Common side effects of Adalimumab may include: injection site reactions upper respiratory tract infection headache and others Always consult with a healthcare professional about potential side effects.

Q: What drug class is Adalimumab?

Adalimumab belongs to the TNF inhibitor drug class.

Q: What is the dosage of Adalimumab and how do I take it?

Administration Adalimumab is given by subcutaneous injection, which means it is injected into the fatty tissue just under the skin. It is available in pre-filled syringes or single-use injection pens. A healthcare provider will typically demonstrate how to prepare and inject the medication so it can be used at home. Common injection sites include the front of the thighs or the abdomen. It is important to rotate the injection site each time, choosing a spot at least one inch away from the previous site. Avoid injecting into skin that is sore, bruised, red, hard, or scarred. Preparation Before using the medication, remove it from the refrigerator and let it sit at room temperature for approximately 15 to 30 minutes. Do not remove the cap or cover while it is warming up. Do not heat the medication in a microwave or with hot water. Check the liquid to ensure it is clear and colorless; do not use it if it is cloudy, discolored, or contains large particles. Do not shake the syringe or pen. Missed Dose If a dose is missed, it should be taken as soon as it is remembered. The next dose should then be taken at the regularly scheduled time. Do not use extra medication to make up for a missed dose.

Q: Is Adalimumab safe during pregnancy and breastfeeding?

Pregnancy Adalimumab should be used during pregnancy only if clearly needed. While it is not expected to be harmful to an unborn baby, the medication can cross the placenta during the third trimester. This exposure may affect the immune system of the newborn. If adalimumab was used during pregnancy, healthcare providers usually recommend waiting at least five months after the last dose before giving the infant any live vaccines. It is important to discuss your pregnancy or plans to become pregnant with your doctor to manage your condition safely. Breastfeeding Limited information is available regarding the use of adalimumab while breastfeeding. Because it is a large protein, it is likely that only small amounts pass into breast milk and even smaller amounts are absorbed by the infant's stomach. However, you should consult with your healthcare provider to determine if breastfeeding is appropriate for your situation while using this medication.

Q: What forms and strengths does Adalimumab come in?

Available Forms Adalimumab is provided as a sterile, preservative-free solution for subcutaneous injection. It is available in several delivery systems designed for either self-administration or use by a healthcare professional: Single-dose pre-filled pens: These devices are designed for ease of use during self-injection. Single-dose pre-filled syringes: These allow for manual administration by the patient, a caregiver, or a provider. Single-dose vials: These are typically used in clinical settings where the dose is drawn into a syringe by a healthcare professional. The medication is a clear, colorless solution. Some formulations are produced without citrate, which may help reduce pain or irritation at the injection site.

Question 1

What is Adalimumab?

Accepted Answer

Adalimumab belongs to a class of medications known as tumor necrosis factor (TNF) blockers. It works by binding to TNF-alpha, a substance produced by the immune system that can cause pain and swelling when present in excess.

By blocking this protein, the medication helps to decrease inflammation and prevent damage to various tissues. It is a monoclonal antibody that targets specific biological processes involved in the immune response.

Question 2

What is Adalimumab used for?

Accepted Answer

Adalimumab is used to treat the following conditions:

Rheumatoid arthritis
Juvenile idiopathic arthritis
Psoriatic arthritis
Others

Question 3

How does Adalimumab work?

Accepted Answer

Mechanism of Action

Adalimumab belongs to a class of medications known as tumor necrosis factor (TNF) blockers. TNF is a protein naturally produced by the immune system that helps regulate the body's inflammatory response. In people with certain autoimmune diseases, the body produces an excess of this protein, which leads to chronic inflammation and tissue damage.

This medication works by targeting and binding to TNF-alpha molecules. By attaching to these proteins, adalimumab prevents them from interacting with receptors on the surface of cells. This process helps to:

Reduce the overall inflammatory response in the body.
Decrease swelling, pain, and stiffness in affected areas, such as the joints, skin, or digestive tract.
Slow the progression of structural damage caused by chronic inflammation.

Because adalimumab specifically targets a component of the immune system to manage disease activity, it is classified as a biologic medication.

Question 4

What are the brand names for Adalimumab?

Accepted Answer

Adalimumab is sold under the brand name Humira.

Question 5

What are the active ingredients in Adalimumab?

Accepted Answer

The active ingredient in Adalimumab is adalimumab.

Question 6

What are the side effects of Adalimumab?

Accepted Answer

Common side effects of Adalimumab may include:

injection site reactions
upper respiratory tract infection
headache
and others

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Adalimumab?

Accepted Answer

Adalimumab belongs to the TNF inhibitor drug class.

Question 8

What is the dosage of Adalimumab and how do I take it?

Accepted Answer

Administration

Adalimumab is given by subcutaneous injection, which means it is injected into the fatty tissue just under the skin. It is available in pre-filled syringes or single-use injection pens. A healthcare provider will typically demonstrate how to prepare and inject the medication so it can be used at home.

Common injection sites include the front of the thighs or the abdomen. It is important to rotate the injection site each time, choosing a spot at least one inch away from the previous site. Avoid injecting into skin that is sore, bruised, red, hard, or scarred.

Preparation

Before using the medication, remove it from the refrigerator and let it sit at room temperature for approximately 15 to 30 minutes. Do not remove the cap or cover while it is warming up. Do not heat the medication in a microwave or with hot water. Check the liquid to ensure it is clear and colorless; do not use it if it is cloudy, discolored, or contains large particles. Do not shake the syringe or pen.

Missed Dose

If a dose is missed, it should be taken as soon as it is remembered. The next dose should then be taken at the regularly scheduled time. Do not use extra medication to make up for a missed dose.

Question 9

Is Adalimumab safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Adalimumab should be used during pregnancy only if clearly needed. While it is not expected to be harmful to an unborn baby, the medication can cross the placenta during the third trimester. This exposure may affect the immune system of the newborn.

If adalimumab was used during pregnancy, healthcare providers usually recommend waiting at least five months after the last dose before giving the infant any live vaccines. It is important to discuss your pregnancy or plans to become pregnant with your doctor to manage your condition safely.

Breastfeeding

Limited information is available regarding the use of adalimumab while breastfeeding. Because it is a large protein, it is likely that only small amounts pass into breast milk and even smaller amounts are absorbed by the infant's stomach. However, you should consult with your healthcare provider to determine if breastfeeding is appropriate for your situation while using this medication.

Question 10

What forms and strengths does Adalimumab come in?

Accepted Answer

Available Forms

Adalimumab is provided as a sterile, preservative-free solution for subcutaneous injection. It is available in several delivery systems designed for either self-administration or use by a healthcare professional:

Single-dose pre-filled pens: These devices are designed for ease of use during self-injection.
Single-dose pre-filled syringes: These allow for manual administration by the patient, a caregiver, or a provider.
Single-dose vials: These are typically used in clinical settings where the dose is drawn into a syringe by a healthcare professional.

The medication is a clear, colorless solution. Some formulations are produced without citrate, which may help reduce pain or irritation at the injection site.

Question 11

What is the FDA approval status of Adalimumab?

Accepted Answer

FDA Approval and Indications

Adalimumab was first approved by the U.S. Food and Drug Administration (FDA) in 2002. It is a tumor necrosis factor (TNF) blocker indicated for the treatment of several autoimmune and inflammatory diseases in adults and, for certain conditions, pediatric patients. Approved indications include:

Rheumatoid arthritis
Juvenile idiopathic arthritis
Psoriatic arthritis
Ankylosing spondylitis
Crohn's disease
Ulcerative colitis
Plaque psoriasis
Hidradenitis suppurativa
Uveitis

Boxed Warning

The FDA requires a boxed warning for adalimumab because it may increase the risk of serious, life-threatening safety issues.

Serious Infections

Patients treated with adalimumab are at increased risk for developing serious infections that may lead to hospitalization or death. These include tuberculosis (TB), bacterial sepsis, and invasive fungal infections (such as histoplasmosis, coccidioidomycosis, or blastomycosis). Healthcare providers are required to test patients for latent TB before starting treatment and monitor them for signs of infection during therapy.

Malignancy

Lymphoma and other malignancies, some fatal, have been reported in children and adolescent patients treated with TNF blockers. Cases of a rare and often fatal cancer called hepatosplenic T-cell lymphoma have occurred, primarily in adolescent and young adult males with inflammatory bowel disease who were also using other immunosuppressive medications.

Biosimilar Availability

The FDA has approved several biosimilar versions of adalimumab. A biosimilar is a biological product that is highly similar to an already approved reference biologic, with no clinically meaningful differences in terms of safety, purity, and potency. Some biosimilars may be designated as interchangeable, meaning they may be substituted for the reference product by a pharmacist depending on state laws.

Question 12

What should I know about Adalimumab and cost?

Accepted Answer

Factors Affecting Cost

The cost of adalimumab can vary significantly based on several factors, including the specific version prescribed, the dosage required, and insurance coverage. As a biologic medication, it is typically more expensive than many other types of drugs.

Biosimilars

There are several biosimilar versions of adalimumab available. These medications are designed to be highly similar to the original biologic and may be available at a lower cost. Availability and coverage for these versions often depend on the specific insurance provider's formulary.

Insurance and Financial Assistance

Insurance companies often require prior authorization for adalimumab, meaning the insurer must approve the treatment before they will cover the cost. Patients may also find the following resources helpful:

Specialty Pharmacies: This medication is usually obtained through a specialty pharmacy that handles high-cost biologic drugs and provides specific storage and delivery services.
Patient Assistance Programs: Many drug manufacturers offer financial assistance or co-pay savings cards to help eligible patients manage out-of-pocket expenses.
Insurance Formularies: Costs can vary depending on which tier the medication occupies within an insurance plan's list of covered drugs.

Adalimumab

📋Overview

How It Works

Uses

Brand Names

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Adalimumab

Hospitals.net Disclosure